Regulation of B cell growth and differentiation via CD21 and CD40
- 1 September 1996
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 26 (9), 2203-2207
- https://doi.org/10.1002/eji.1830260936
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired ImmunityScience, 1996
- Abnormal B lymphocyte delevopment, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction moleculeImmunity, 1995
- A subset of anti‐CD21 antibodies promote the rescue of germinal center B cells from apoptosisEuropean Journal of Immunology, 1993
- Recombinant 25‐kDa CD23 and interleukin 1α promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosisEuropean Journal of Immunology, 1991
- Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50.Proceedings of the National Academy of Sciences, 1986
- Assays for Lymphokines Supporting B Cell GrowthPublished by Elsevier ,1985
- Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.Proceedings of the National Academy of Sciences, 1984
- Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor-specific antibody.Proceedings of the National Academy of Sciences, 1981
- Use of Monoclonal Anti-mouse Immunoglobulin to Detect Mouse AntibodiesHybridoma, 1981
- TWO DIFFERENT COMPLEMENT RECEPTORS ON HUMAN LYMPHOCYTESThe Journal of Experimental Medicine, 1973